Catheters Market Competitive Landscape : Business Market Insights

Komentari · 26 Pogledi

The catheters market size is expected to reach US$ 133,987.1 million by 2033 from US$ 61,000.3 million in 2024. The market is estimated to record a CAGR of 9.4% from 2025 to 2033.

The Catheters Market features a highly competitive group of global medical device leaders, and this Catheters Market Competitive Landscape analysis reveals how their product innovation strategies, regulatory achievements, strategic partnerships, and geographic expansion activities are collectively shaping the market's evolution toward more advanced, safer, and patient-centered catheter solutions. The market's projected growth from US$ 61,000.3 million in 2024 to US$ 133,987.1 million by 2033 continues to attract sustained and intensifying competitive investment.

Request Sample Pages of this Research Study @ https://www.businessmarketinsights.com/sample/BMIPUB00031919

Key Market Players

  • Medtronic Plc
  • Boston Scientific Corp
  • Becton, Dickinson and Co
  • Teleflex Inc
  • B. Braun SE
  • Abbott Laboratories
  • Terumo Corp
  • Coloplast AS
  • Cook Medical Holdings LLC
  • Hollister Inc

Medtronic Plc is one of the most strategically active players in the catheters market, with a broad portfolio spanning cardiovascular, neurovascular, and specialty catheter categories. In April 2025, Medtronic announced that its IN. PACT AV drug-coated balloon catheter will be reimbursed in Korea starting in May for use in dialysis patients experiencing early re-narrowing of vascular access sites. This reimbursement expansion for the management of stenotic lesions in end-stage renal disease patients underscores Medtronic's strategy of securing geographic reimbursement coverage for its premium catheter portfolio, driving market access expansion across key Asia-Pacific markets.

Becton, Dickinson and Co has reinforced its competitive position in the central venous access segment through the April 2025 FDA approval of the BD CentroVena Central Venous Catheter with CentroVena One Insertion System. Designed for short-term central venous access to administer fluids, blood products, and drugs, and for blood withdrawal and central venous pressure monitoring including power injection capabilities, this approval expands BD's acute vascular access offerings with a clinically differentiated system that simplifies insertion and expands functional capabilities for clinical users.

Boston Scientific Corp brings extensive cardiovascular and peripheral catheter expertise to the competitive landscape, with balloon catheter and electrophysiology catheter products serving the high-volume interventional cardiology and cardiac electrophysiology markets. Abbott Laboratories contributes strong vascular and structural heart catheter capabilities. Teleflex and B. Braun SE serve broad catheter portfolio categories across vascular access, urology, and specialty applications. Coloplast AS and Hollister Inc are specialized leaders in urological catheters, including intermittent and Foley catheter products for both institutional and home care markets. Terumo Corp and Cook Medical contribute cardiovascular intervention and specialty catheter expertise with strong Asian and global market presences.

About Us

Business Market Insights is a one-stop industry research provider of actionable intelligence. Specializing in industries including Manufacturing and Construction, Semiconductor and Electronics, Healthcare, and more, the firm publishes over 500 research reports annually.

Contact Us

If you have any queries about this report or if you would like further information, please contact us: Phone: +16467917070 E-mail: sales@businessmarketinsights.com

Komentari